Zacks Research Has Bearish Outlook for PCRX FY2024 Earnings
Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) – Equities research analysts at Zacks Research cut their FY2024 EPS estimates for Pacira BioSciences in a research report issued to clients and investors on Tuesday, February 11th. Zacks Research analyst R. Department now forecasts that the company will post earnings of $2.61 per share for the year, […]
Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) – Equities research analysts at Zacks Research cut their FY2024 EPS estimates for Pacira BioSciences in a research report issued to clients and investors on Tuesday, February 11th. Zacks Research analyst R. Department now forecasts that the company will post earnings of $2.61 per share for the year, […]
